The Point-Of-Care Molecular Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Point-Of-Care Molecular Diagnostics Market?
The Point-Of-Care Molecular Diagnostics market, previously grown at a rapid pace, was valued at $3.55 billion in 2024. It is predicted to expand to $4.01 billion in 2025, with a compound annual growth rate (CAGR) of 12.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Point-Of-Care Molecular Diagnostics Industry?
The Point-Of-Care Molecular Diagnostics Global Market is anticipated to grow to a value of $7.02 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%.
Download Your Free Sample of the 2025 Point-Of-Care Molecular Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Point-Of-Care Molecular Diagnostics Market?
The key drivers in the point-of-care molecular diagnostics market are:
• Growth is driven by the miniaturization of diagnostic devices, making them more easily accessible.
• The increase in point-of-care testing specifically for cancer and genetic diseases is a significant contributor.
• There is a rising demand for customized molecular diagnostics catered to diverse applications.
• The integration of AI and machine learning for data analysis in diagnostics is fueling expansion in the market.
Global Market Segmentation: Identifying Major Point-Of-Care Molecular Diagnostics Industry Segments
The point-of-care molecular diagnostics market covered in this report is segmented –
1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services
2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing
3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology
4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
Pre-order the 2025 Point-Of-Care Molecular Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Point-Of-Care Molecular Diagnostics Market?
The key trends in the esim market are:
• The trend of miniaturization of diagnostic devices and customized molecular diagnostics for diverse applications is shaping the market.
• Integration of artificial intelligence and machine learning for data analysis in point-of-care molecular diagnostics is an emerging trend.
• Lab-on-chip and microfluidic technologies, and digital health with smartphone-based diagnostics are becoming increasingly popular.
• Point-care-Covid19 and pandemic preparedness, AI-driven predictive diagnostics, and CRISPR-based molecular testing are other significant trends impacting the market.
Who Are the Top Competitors & Leading Players in the Point-Of-Care Molecular Diagnostics Market?
Major companies in the point-of-care molecular diagnostics market are:
• Abbott Laboratories
• F Hoffmann-La Roche Ltd.
• BioMérieux SA
• Danaher Corporation
• Quidel Corporation
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Sysmex Corporation
• Illumina Inc.
• Myriad Genetics Inc.
• Siemens Healthcare GmbH
• Almac Group
• Biogenex Laboratories Inc.
• Cepheid Inc.
• Epic Sciences Inc.
• Foundation Medicine Inc.
• Genomic Health Inc.
• Grail Inc.
• Hologic Inc.
• HTG Molecular Diagnostics Inc.
• Inivata Ltd.
• Invivoscribe Inc.
• MolecularMD Corporation
• Natera Inc.
• NeoGenomics Laboratories Inc.
• Personal Genome Diagnostics Inc.
• Prometheus Laboratories Inc.
• Ventana Medical Systems Inc.
• Vermillion Inc.
• Guardant Health Inc.
• Exact Sciences Corporation
• Biocartis Group NV
• ArcherDx Inc.
• AccuBiotech Co. Ltd.
• Becton, Dickinson and Company
• Chembio Diagnostics Inc.
• Credo Diagnostics Biomedical Pvt. Ltd.
• EKF Diagnostics
• GenePOC Inc.
Regional Dominance: Which Area Leads the Global Point-Of-Care Molecular Diagnostics Market?
North America was the largest region in the point-of-care molecular diagnostics market in 2024
